Home/Filings/4/0001209191-12-045282
4//SEC Filing

Snell Todd M 4

Accession 0001209191-12-045282

CIK 0001333170other

Filed

Sep 11, 8:00 PM ET

Accepted

Sep 12, 4:44 PM ET

Size

7.5 KB

Accession

0001209191-12-045282

Insider Transaction Report

Form 4
Period: 2012-09-10
Snell Todd M
SVP, QA, Reg.&Clinical Affairs
Transactions
  • Award

    Stock Option (right to buy)

    2012-09-10+21,84821,848 total
    Exercise: $13.34From: 2013-09-10Exp: 2019-09-09Common Stock (21,848 underlying)
  • Award

    Common Stock

    2012-09-10+7,7577,757 total
Footnotes (2)
  • [F1]Executive was granted a time-based restricted stock unit award of 7,757 shares of common stock of the Company, with such grant to be made on the first day of Executive's employment with the Company, and vesting in equal installments on a quarterly basis over a period of thirty-six months. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock.
  • [F2]This stock option vests as to 25% of the underlying shares on September 10, 2013 and then in 36 equal monthly installments thereafter.

Issuer

NxStage Medical, Inc.

CIK 0001333170

Entity typeother

Related Parties

1
  • filerCIK 0001557835

Filing Metadata

Form type
4
Filed
Sep 11, 8:00 PM ET
Accepted
Sep 12, 4:44 PM ET
Size
7.5 KB